Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: Long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

  1. Sanz, M.A.
  2. Montesinos, P.
  3. Vellenga, E.
  4. Rayón, C.
  5. De La Serna, J.
  6. Parody, R.
  7. Bergua, J.M.
  8. León, A.
  9. Negri, S.
  10. González, M.
  11. Rivas, C.
  12. Esteve, J.
  13. Milone, G.
  14. González, J.D.
  15. Amutio, E.
  16. Brunet, S.
  17. García-Laraña, J.
  18. Colomer, D.
  19. Calasanz, M.J.
  20. Chillón, C.
  21. Barragán, E.
  22. Bolufer, P.
  23. Lowenberg, B.
Revue:
Blood

ISSN: 0006-4971,  1528-0020

Année de publication: 2008

Volumen: 112

Número: 8

Pages: 3130-3134

Type: Article

DOI: 10.1182/BLOOD-2008-05-159632 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable